Enzolytics, Inc. (OTCMKTS:ENZC) Sees Large Decline in Short Interest

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totalling 200 shares, a drop of 99.7% from the December 31st total of 57,300 shares. Based on an average trading volume of 7,205,900 shares, the short-interest ratio is currently 0.0 days.

Enzolytics Stock Up 12.5 %

Enzolytics stock traded up $0.00 during midday trading on Thursday, reaching $0.00. The stock had a trading volume of 9,408,679 shares, compared to its average volume of 5,436,554. Enzolytics has a 12 month low of $0.00 and a 12 month high of $0.02.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.